Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery
Yuki Kitano, Yosuke Inoue, Tsuyoshi Takeda, Atsushi Oba, Yoshihiro Ono, Takafumi Sato, Hiromichi Ito, Masato Ozaka, Takashi Sasaki, Naoki Sasahira, Hideo Baba, Yu Takahashi
Topics & Concepts
MedicineGemcitabineSurgical oncologyHazard ratioRegimenInternal medicineOncologyChemotherapyPancreatic ductal adenocarcinomaAdenocarcinomaAdjuvantSurvival rateGastroenterologyNeoadjuvant therapyPancreatic cancerSurgeryCancerConfidence intervalBreast cancerPancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesPancreatitis Pathology and Treatment